Clinical NewsCorrectionOct 4, 2004 In our last Letter from the Editor, we incorrectly reported the name of Schering's Primovist MRI contrast agent in our story about European Union approval of the product.Latest in Clinical NewsSimonMed Imaging launches two new AI-enhanced mammogram servicesJuly 7, 2025Both standard and ultrahigh resolution modes effective for PCCT CCTAJuly 3, 2025GAE with stem cells effective for knee osteoarthritisJuly 3, 2025SNMMI commends FDA for approving amyloid imaging agentsJuly 3, 2025Related StoriesBreastWhen push comes to shove: Addressing compression in mammographyBreastPreparation key to surviving MQSA inspectionsClinical NewsBiochem enters ultrasound domain in fetal screeningBreastBreast Imaging: The Requisites
